Why is the Nanosonics share price jumping 10% on Wednesday?

Nanosonics shares are jumping on Wednesday…

| More on:
Three businesspeople leap high with the CBD in the background.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Nanosonics Ltd (ASX: NAN) share price is having a very strong day on Wednesday.

In afternoon trade, the infection prevention company's shares are up over 10% to $3.96.

What's going on with the Nanosonics share price?

Investors have been bidding the Nanosonics share price higher today despite there being no news out of the company.

However, it is worth highlighting that the healthcare sector is performing strongly today, as are a range of beaten down shares.

In respect to the former, in afternoon trade the S&P/ASX 200 Health Care index is up a sizeable 2%. That's despite the ASX 200 index trading 0.5% at the time of writing.

As for the latter, a number of beaten down ASX shares are recording double digit gains on Wednesday. This includes the likes of Life360 Inc (ASX: 360), Megaport Ltd (ASX: MP1), Mesoblast limited (ASX: MSB), and Zip Co Ltd (ASX: ZIP).

Some investors appear to believe that the selling has been overdone and now is the time to pounce.

Anything else?

Nanosonics is one of the most shorted shares on the Australian share market. At the last count, the company had over 12% of its shares in the hands of short sellers.

If some short sellers have decided to close positions, then they could be boosting the buy side by buying shares today.

Whatever the reason, with the Nanosonics share price still down ~40% in 2022, shareholders will no doubt be hoping there are more strong gains to come.

Motley Fool contributor James Mickleboro has positions in Life360, Inc. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Life360, Inc., MEGAPORT FPO, Nanosonics Limited, and ZIPCOLTD FPO. The Motley Fool Australia has positions in and has recommended Nanosonics Limited. The Motley Fool Australia has recommended MEGAPORT FPO. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

A young woman holds an open book over her head with a round mouthed expression as if to say oops as she looks at her computer screen in a home office setting with a plant on the desk and shelves of books in the background.
Healthcare Shares

This ASX All Ords share is diving 18% as inflation pain draws blood

This healthcare company delivered a trading update at its annual general meeting today.

Read more »

Shot of a young scientist using a digital tablet while working in a lab.
Healthcare Shares

Up 427% this year, why today is a big day for Mesoblast shares

Why is everyone talking about Mesoblast shares on Friday?

Read more »

A man holds his hand under his chin as he concentrates on his laptop screen and reads about the ANZ share price
Healthcare Shares

Is this beaten-down ASX healthcare share a bargain buy now?

One expert has given their view on this stock.

Read more »

drug capsule opening up to reveal dollar signs signifying rising asx share price
Healthcare Shares

3 ASX healthcare shares going gangbusters on Thursday

Investors are sending these ASX healthcare stocks soaring today. But why?

Read more »

Two lab workers fist pump each other.
Healthcare Shares

Is it time to cash in on Sigma shares?

Shares have extended after the Chemist Warehouse merger.

Read more »

Person holding Australian dollar notes, symbolising dividends.
Healthcare Shares

Buy this ASX 200 share that is swimming in cash

Bell Potter sees potentially big returns on offer from this cashed-up stock.

Read more »

Shot of a scientist using a computer while conducting research in a laboratory.
Healthcare Shares

Are CSL shares a buy after the biotech's FY25 forecasts?

Brokers continue to weigh in.

Read more »

Female pharmacist smiles with a digital tablet.
Healthcare Shares

Are Wesfarmers or Sigma shares a better buy in the pharmacy arena?

These two stocks are both leaders in the industry.

Read more »